PROM1 and glioblastoma: The results demonstrated that both CD133+ and CD133− cells are capable of initiating proneural GBM tumors; however, CD133+ cells had a greater association with angiogenesis and, therefore, could lead to the formation of more aggressive tumor phenotypes [20].